Last reviewed · How we verify
NCT02567981
Impact of the Consumption of an M+ Fortified Premix (Chapuditos®) in 4 Rural Municipalities in the Department of La Libertad, El Salvador in Children From 6 to 59 Months.
NA trial testing 21 micronutrient-fortified supplement in Micronutrient Deficiency in 4,577 participants. Status unknown.
1 September 2020
Quick facts
| Lead sponsor | The Mathile Institute for the Advancement of Human Nutrition |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 4,577 |
| Start date | 1 September 2015 |
| Primary completion | 1 September 2020 |
| Estimated completion | 1 September 2020 |
| Sites | 1 location across El Salvador |
Drugs / interventions tested
- 21 micronutrient-fortified supplement
- Cereal Fortificado (Fortified Cereal)
- Ferrous sulphate — full drug profile →
- Vitamin A — full drug profile →
Conditions studied
- Micronutrient Deficiency — all drugs for Micronutrient Deficiency →
Sponsor
The Mathile Institute for the Advancement of Human Nutrition
Who can join
Adults 6 Months to 59 Months, any sex, with Micronutrient Deficiency. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Changes in mean hemoglobin concentrations
Time frame: Every six months after enrollment until child reaches 60 months of age or until study completion -
Prevalence of anemia
Time frame: Every six months after enrollment throughout study completion, and/or until child reaches 60 months of age, and/or until study is completed.
Anemia is defined as hemoglobin \<11.0g/dL. -
Changes in mean length/height-for age z-scores (HAZ)
Time frame: Every three months after enrollment throughout study completion, and/or until child reaches 60 months of age.
Z scores will be calculated based on 2006 child WHO growth standards -
Prevalence of stunting defined as HAZ<-2SD below median.
Time frame: Every three months after enrollment throughout study completion, and/or until child reaches 60 months of age.
Z scores will be calculated based on 2006 child WHO growth standards -
Incidence of acute respiratory tract infections
Time frame: Monthly from after enrollment throughout study completion, and/or until child reaches 60 months of age.
Respiratory tract infections definition: any infectious disease of the upper or lower respiratory tract. Caregivers will answer on a monthly basis a brief morbidity questionnaire. -
Incidence of diarrhea
Time frame: Monthly from enrollment throughout study completion, and/or until child reaches 60 months of age.
Diarrhea definition (WHO): " three or more loose or liquid stools per day (or more frequent passage than is normal for the individual)". Termination of an episode is defined when associated symptoms have been absent for more than 48 hours. Caregivers will answer on a monthly basis a brief morbidity questionnaire.
Sponsor's own description
Adequate nutrition during the first years of life is essential to reach full body and brain development potential. Children under the age of 5 in Central America and El Salvador suffer from micronutrient deficiencies. In El Salvador, \~ 20% of children under the age of 5 suffer from chronic undernutrition which is reflected in low length-for-their age Z-scores and anemia. This trial will examine the impact on health and growth in young children that will receive either a 21 micronutrient fortified cereal/legume mix manufactured in Guatemala or the current standard of nutritional care. The ultimate goal is to identify other feasible and effective alternatives to prevent micronutrient deficiencies through culturally acceptable vehicles.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
- PubMed search for NCT02567981
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02567981 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Mathile Institute for the Advancement of Human Nutrition
- Last refreshed: 12 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02567981.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing